Open House Discount Agreements for Flupentixol, ATC N05AF01
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or minimum purchase commitment – contracts are non-exclusive and may be terminated if a competitiv...
Complex submission requirements: paper copies or qualified electronic signature; missing documents can be requested but...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Nov 2026
- Non-exclusive discount agreements for pharmaceutical product Flupentixol (ATC N05AF01)
- Place of performance: Bavaria, Germany (DE212)
Show full summary
Open house model for non-exclusive discount agreements on Flupentixol (ATC N05AF01) with AOK Bayern. All interested pharmaceutical companies meeting eligibility can join. No selection, no competition. Contracts from 01.12.2024 to 30.11.2026. No estimated value provided.
Risks
No guaranteed volume or minimum purchase commitment – contracts are non-exclusive and may be terminated if a competitiv...
Complex submission requirements: paper copies or qualified electronic signature; missing documents can be requested but...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible as potential contract partners
Administrative
- Documents must be in German or accompanied by a German translation
- Submission in paper (two original copies) or electronically with qualified electronic signature
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open House Discount Agreements for Flupentixol, ATC N05AF01
Non-exclusive discount agreement for Flupentixol in Bavaria, Germany. Open house model: all eligible pharmaceutical companies can join. No competition or selection process.
Location
Duration
Category
Award Criteria
Deadline
Award details
Siehe kurze Beschreibung
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Flupentixol, ATC N05AF01
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Oct 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 630058-2024
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No guaranteed volume or minimum purchase commitment – contracts are non-exclusive and may be terminated if a competitiv...
Complex submission requirements: paper copies or qualified electronic signature; missing documents can be requested but...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications